It is a healthcare private limited company based in New Delhi, Delhi, India, established in 2013.
2013 | New Delhi, Delhi, India | ActiveIndel Pharmaceuticals Private Limited, a active private limited company, was established on 03 May 2013 in New Delhi, Delhi, India. Engaging in other hospital and medical care activities within the trade sector, it holds CIN: U85100DL2013PTC251577. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Chander Kanta (Director), Nidhi Sahrawat (Director). Past directors included Rupa Ashokbhai Arora, Manish Sahrawat. Its latest AGM occurred on 30 September 2019, with the balance sheet filed on 31 March 2019. It is based at House No-522 Village Daryapur, New Delhi, Delhi, 110039.
U85100DL2013PTC251577
251577
03 May 2013
₹0.10 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Indel Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Chander Kanta | Director | 03 May 2013 | Current |
| Nidhi Sahrawat | Director | 18 Apr 2015 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 17 Jan 2015 | Past |
| Pramod Abcsdd | Director | 25 Nov 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Indel Pharmaceuticals Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2017, Indel Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Indel Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Indel Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Indel Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Indel Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2019 as per latest MCA records. was documented.
Indel Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Delhi. was recorded as a recent event.
Progress on Nidhi Sahrawat was appointed as a Director was appointed as a Director on 18 Apr 2015 & has been associated with this company since 10 years 8 months . was documented.
Chander Kanta was appointed as a Director was appointed as a Director on 03 May 2013 & has been associated with this company since 12 years 7 months . was recorded as a recent event.
Indel Pharmaceuticals Private Limited was registered on 03 May 2013 with Roc Delhi & aged 12 years 7 months as per MCA records. was recorded as a recent event.
The CIN of Indel Pharmaceuticals Private Limited is U85100DL2013PTC251577.
Indel Pharmaceuticals Private Limited is headquartered at House No-522 Village Daryapur, New Delhi, Delhi, 110039.
Indel Pharmaceuticals Private Limited was incorporated on 03 May 2013.
The current directors of Indel Pharmaceuticals Private Limited are
The primary industry of Indel Pharmaceuticals Private Limited is Trade.
Indel Pharmaceuticals Private Limited is unlisted.
The authorized capital of Indel Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Indel Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX